Executive Office of the President
Research and Data Analysis
Key facts
- Open now
- None right now
- Closed for this year
- 1 grant, next round estimated
- Type of help
- Cooperative agreement (a grant with close agency involvement)
- Typical award
- $150,000 to $3,000,000
Closed for this year
This year's round is over. GrantMe estimated the next round from last year's dates.
- Improving the Capacity of Tribal Communities to Identify Emerging Drug Threats · Next round: about Sep 2 – Sep 13, 2027 Estimate, not confirmed by the funder
What it pays for
The purpose of research and data analysis is to inform policy formulation and assessment. The work involves research and analysis of data as it pertains to drug policy.
Who can apply
Applicants must have expert knowledge and extensive experience in conducting research and analysis to include higher educational institutions and hospitals. Applicants must also ensure compliance with all federal laws, regulations, Executive Orders, and public policies governing financial assistance awards.
How applications are judged
Applications will not be considered that fail to demonstrate the organization�s expertise and extensive experience in drug research and data analysis.
Match
Match: none required (federal program listing). Statutory Formula: Title 2, Part 3603, Subpart 1,Public Law P.L. 109-469.Authority: 21 U.S.C. 1706; 21 U.S.C. 1703(d), 1703(f), 21 U.S.C. 1701, 21 U.S.C. 1521-1548, 21 U.S.C. 2001-2003, Office of National Drug Control Policy Reauthorization Act of 2006, P.L 109-469 (2006), 2 CFR part 200.
Source: 79 FR 76105, Dec. 19, 2014, unless otherwise noted.
� 3603.1 Adoption of 2 CFR Part 200.
Under the authority listed above, the Executive Office of the President, Office of National Drug Control Policy (ONDCP) adopts the Office of Management and Budget (OMB) Guidance in 2 CFR part 200. Thus, this part gives regulatory effect to the OMB guidance and supplements the guidance as needed for ONDCP.